IE
CAI

Israel Englander’s Caris Life Sciences CAI Stock Holding History

Israel Englander’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.3M Buy
2,202,647
+674,891
+44% +$12.1M 0.01% 1050
2026
Q1 		$27.3M Sell
1,527,756
-2,124,891
-58% -$46.4M 0.01% 1291
2025
Q4 		$98.5M Sell
3,652,647
-285,425
-7% -$8.04M 0.04% 439
2025
Q3 		$119M Buy
3,938,072
+424,896
+12% +$13.5M 0.05% 356
2025
Q2 		$93.9M Buy
+3,513,176
New +$94.7M 0.05% 427

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Israel Englander's CAI Position: Q2 2026 in Review

Israel Englander increased its Caris Life Sciences (CAI) stake by 44% in Q2 2026, buying an estimated $12.1M and bringing the position to 2,202,647 shares worth $39.3M. The position accounts for 0.01% of the portfolio, ranked #1050.

Israel Englander first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. The position peaked at $119M in Q3 2025. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Israel Englander held 2,202,647 shares of Caris Life Sciences worth $39.3M as of Q2 2026.
  • Israel Englander bought 674,891 Caris Life Sciences shares in Q2 2026, an estimated $12.1M.
  • Caris Life Sciences made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1050 holding.
  • Israel Englander first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • Israel Englander's Caris Life Sciences position peaked at $119M in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.